Related Experiment Video

Updated: May 17, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Amycolamicin: a novel broad-spectrum antibiotic inhibiting bacterial topoisomerase

Ryuichi Sawa1, Yoshiaki Takahashi, Hideki Hashizume

  • 1Institute of Microbial Chemistry, BIKAKEN, Tokyo, Japan.

Chemistry (Weinheim an Der Bergstrasse, Germany)
|November 7, 2012
PubMed

Insights

Researchers discovered a new antibiotic, amycolamicin (AMM), effective against multidrug-resistant bacteria. AMM targets bacterial DNA gyrase, offering a novel mechanism to combat resistant pathogens.

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • Antibiotic drug abuse drives the evolution of multidrug resistance in bacterial pathogens.
  • Novel antibiotic classes are urgently needed to combat emerging resistant strains.

Purpose of the Study:

  • To report the discovery and structural elucidation of a novel antibiotic, amycolamicin (AMM).
  • To investigate the antibacterial spectrum and mechanism of action of AMM.

Main Methods:

  • Absolute structure determination using NMR spectroscopy, X-ray analysis, and chemical modifications.
  • Assessment of antibacterial activity against Gram-positive pathogens.
  • Inhibition assays targeting DNA gyrase and bacterial topoisomerase IV.

Main Results:

  • Amycolamicin (AMM) was discovered, possessing a complex structure including trans-decalin, tetramic acid, unusual sugars, and dichloropyrrole carboxylic acid.
  • AMM exhibits potent, broad-spectrum activity against Gram-positive pathogenic bacteria.
  • AMM inhibits DNA gyrase B subunit, with a distinct binding mode compared to known inhibitors.

Conclusions:

  • Amycolamicin represents a novel class of antibiotics with significant potential against multidrug-resistant bacteria.
  • Its unique mechanism of action targeting DNA gyrase offers a new strategy for antibiotic development.

More Related Videos

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins05:57

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins

Published on: April 26, 2024

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...